Pace Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Ternary Therapeutics
16 Mar 2026
Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
Ternary Therapeutics develops computational and laboratory tools to design molecular glue medicines. Its platform predicts how proteins interact and suggests molecules that can bring them together, helping researchers target disease-driving proteins previously considered undruggable.
Bitfount
23 Jul 2025
Bitfount raises £6m Series A led by Parkwalk to scale privacy-preserving AI for clinical trials
Bitfount provides federated AI infrastructure for clinical research, allowing hospitals and pharmaceutical companies to collaborate on trials and analysis without sharing sensitive patient data.
Pace Ventures
- 2(12 months)
- paceventures.com
- Update Information
More venture news
- 16 Mar 2026
Ternary TherapeuticsTernary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
SeedLife Sciences - 12 Mar 2026
LoxaLoxa raises a £2.7m seed round for embedded product protection at checkout
SeedCommerce - 11 Mar 2026
Spotlight PathologySpotlight Pathology lands a £1.4m seed round led by UK Innovation and Science Seed Fund to help in the diagnosis of blood cancers with AI-powered tools
SeedHealth
